this post was submitted on 04 Sep 2023
126 points (100.0% liked)

Science

13009 readers
11 users here now

Studies, research findings, and interesting tidbits from the ever-expanding scientific world.

Subcommunities on Beehaw:

Be sure to also check out these other Fediverse science communities:

This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS
Gaywallet@beehaw.org
alyaza@beehaw.org
remington@beehaw.org
126
Brain's Weight Switch Found: May Let Us Eat What We Want, Finally (neurosciencenews.com)
submitted 1 year ago by will_a113@lemmy.ml to c/science@beehaw.org
57 comments fedilink hide all child comments
 

A new discovery reveals that astrocytes, star-shaped cells in the brain, play a key role in regulating fat metabolism and obesity. These cells act on a cluster of neurons, known as the GABRA5 cluster, effectively acting as a “switch” for weight regulation.

The MAO-B enzyme in these astrocytes was identified as a target for obesity treatment, influencing GABA secretion and thus weight regulation.

KDS2010, a selective and reversible MAO-B inhibitor, successfully led to weight loss in obese mice without impacting their food intake, even while consuming a high-fat diet, and is now in Phase 1 clinical trials.

you are viewing a single comment's thread
view the rest of the comments
[–] RobotToaster@infosec.pub 5 points 1 year ago* (last edited 1 year ago)

KDS2010, a selective and reversible MAO-B inhibitor

This seems like a really odd result. We already have MAOI drugs, they were the first class of antidepressant drugs invented accidentally in the 50s when they found the tuberculosis drug iproniazid made people happier. The selective and reversible MAO-B inhibitor selegiline has been used for years to treat parkinson's disease. None of these drugs are known to induce weight loss.